Clinical trial · Interventional
Erectile Rating During the Treatment of Rectal Cancers Localized
Erectile Rating During the Treatment of Rectal Cancers Localized. Exploratory Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Sexual dysfunction is a common side effect of medical and surgical treatments for rectal cancer. It can manifest as ejaculation disorders or erectile dysfunction. Due to the modesty of both patients and doctors, these disorders are poorly understood and probably underestimated at present. Aim : Objectively assess the presence of erectile dysfunction induced by medical and surgical treatment of rectal cancer three months after surgery. These objective data will be obtained using the RIGISCAN® PLUS system coupled with polysomnographic recording.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Rectal Cancer Stage I | Malignant Rectal Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Evaluation of erectile dysfunction | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Patients with localized rectal cancer
- description
- Assessment (at night) of erctile dysfunction using R/P recording (RIGISCAN® PLUS / polysomonography)
- interventionNames
- Other: Evaluation of erectile dysfunction
Primary outcomes (1)
- measure
- Proportion of Patients With Erectile Dysfunction Induced by Medical and Surgical Treatment of Rectal Cancer
- timeFrame
- 3 months after surgery
- description
- Erectile dysfunction is defined by the absence of normal nocturnal erections according to R/P recording (RIGISCAN® PLUS / polysomnography)
Secondary outcomes (1)
- measure
- Quality of Nocturnal Erections
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Male patient. 2. Age greater than 18 years. 3. Neoplastic rectal stage ≤ T3. 4. Patient sexually active before diagnosis. 5. Laparoscopic surgery. 6. Medico-surgical institute Bergonié. 7. Patient information and consent for participation in the study. Exclusion Criteria: 1. Patients already treated for erectile dysfunction. 2. Absence of sexual activity before diagnosis. 3. Presence of secondary lesions at diagnosis (M +). 4. Classified T4 tumor preoperatively. 5. Surgery by laparotomy. 6. History of pelvic cancer surgery prostate or bladder. 7. History of pelvic radiotherapy (outside of the current process). 8. History of prostate or bladder neoplasia known. 9. Other neoplastic known. 10. Patient for psychological, social, family or geographical could not be treated or monitored regularly according to the criteria of the study, patient deprived of liberty or under guardianship.
References
Publications (0)
Data not yet available